These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 19107439)

  • 1. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear matrix proteins as biomarkers for breast cancer.
    Lüftner D; Possinger K
    Expert Rev Mol Diagn; 2002 Jan; 2(1):23-31. PubMed ID: 11963799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of four serological tumor markers for the detection of breast cancer.
    Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
    Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biomarkers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1021-6. PubMed ID: 15272579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
    Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
    Watson AP; Egland KA
    S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.
    Ambeba E; Linkov F
    Future Oncol; 2011 Dec; 7(12):1399-414. PubMed ID: 22112316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteome analysis for identification of tumor-associated biomarkers in breast cancer].
    Wang X; Liang WJ; Zhu ZY; Yang MT; Zeng YX
    Ai Zheng; 2004 Nov; 23(11 Suppl):1577-81. PubMed ID: 15566683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
    Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
    Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers in gynecological and breast cancer].
    Jobo T; Sato R; Kuramoto H
    Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum proteome profiling of primary breast cancer indicates a specific biomarker profile.
    Böhm D; Keller K; Wehrwein N; Lebrecht A; Schmidt M; Kölbl H; Grus FH
    Oncol Rep; 2011 Nov; 26(5):1051-6. PubMed ID: 21837365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooling of case specimens to create standard serum sets for screening cancer biomarkers.
    Skates SJ; Horick NK; Moy JM; Minihan AM; Seiden MV; Marks JR; Sluss P; Cramer DW
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):334-41. PubMed ID: 17301268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 15-3: uses and limitation as a biomarker for breast cancer.
    Duffy MJ; Evoy D; McDermott EW
    Clin Chim Acta; 2010 Dec; 411(23-24):1869-74. PubMed ID: 20816948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of novel biological tools used in screening for the early detection of lung cancer.
    Ghosal R; Kloer P; Lewis KE
    Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving role of proteomics in the early detection of breast cancer.
    Pawlik TM; Kuerer HM
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):212-6. PubMed ID: 16468471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for breast cancer: current recommendations and future directions.
    Knutson D; Steiner E
    Am Fam Physician; 2007 Jun; 75(11):1660-6. PubMed ID: 17575656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models.
    Hwa HL; Kuo WH; Chang LY; Wang MY; Tung TH; Chang KJ; Hsieh FJ
    J Eval Clin Pract; 2008 Apr; 14(2):275-80. PubMed ID: 18284517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and diagnosis of breast cancer in augmented women.
    Uematsu T
    Breast Cancer; 2008; 15(2):159-64. PubMed ID: 18293060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.